27 Oct 2015 14:04
For immediate release | 27 October 2015 |
ABCAM PLC
("Abcam" or "the Company")
Director/PDMR Shareholding: Share Incentive Plan
Cambridge, UK: Abcam plc (AIM: ABC), a global leader in the supply of life science research tools, has been notified today that on 26 October 2015, the following transactions to the benefit of Directors and PDMR, arising from the annual invitation to all UK based employees to participate in the Abcam plc Share Incentive Plan:
Directors:
Name | Partnership Shares purchased on 26 October 2015 at 598.50p | Matching Shares granted on 26 October 2015 at 598.50p | Free Shares awarded on 26 October 2015 at 598.50p
|
Alan Hirzel | 301 | 301 | 601 |
Jim Warwick | 301 | 301 | 601 |
Jeff Iliffe | 301 | 301 | 601 |
PDMR:
Name | Partnership Shares purchased on 26 October 2015 at 598.50p | Matching Shares granted on 26 October 2015 at 598.50p | Free Shares awarded on 26 October 2015 at 598.50p
|
Suzanne Smith | 300 | 300 | 601 |
The risk of forfeiture attached to the Matching Shares will normally be removed on the third anniversary of the award subject to continued employment and the retention of the Partnership Shares in connection with which they were awarded. The risk of forfeiture attached to the Free Shares will normally be removed on the third anniversary of the award subject to continued employment.
The above grantees paid the consideration for the Partnership Shares purchased on their behalf, but no consideration was paid by the above grantees in respect of the award of the Matching and Free Shares and no consideration will be due on the release of these shares.
For further information please contact:
Abcam | + 44 (0) 1223 696 000 |
Suzanne Smith, Company Secretary
| |
J.P.Morgan Cazenove - Nominated Adviser & Joint Corporate Broker | + 44 (0) 20 7742 4000 |
James Mitford / Alex Bruce - Nominated Adviser | |
Peel Hunt LLP - Joint Corporate Broker | + 44 (0) 20 7418 8900 |
Jock Maxwell MacDonald - Corporate Broking | |
Notes to Editors
About Abcam
Abcam plc is a global leader in the supply of life science research tools, with a wide range of products and expert technical support, enabling scientists to analyse living cells at the molecular level and improving the understanding of health and disease.
Abcam is committed to providing scientists with an extensive choice of reagents and tools, with the most comprehensive, honest and up-to-date datasheets and customer reviews, fast delivery and helpful customer service & technical support. The Company's catalogue evolves with scientific research trends and is growing each year to provide customers with products to meet their research needs. The range now includes primary and secondary antibodies, proteins, peptides, lysates, biochemicals, immunoassays and other kits. Abcam also supports its customers by hosting a range of global scientific events, forums and webinars, providing opportunities for scientists to get together and present their work.
Headquartered in Cambridge, UK, Abcam has nine global subsidiary offices enabling local services and multi-language support and sells to over 100 countries. The Company was founded in 1998, and now employs over 820 people. Abcam was admitted to AIM in 2005 (AIM: ABC).
To find out more, please visit www.abcam.com